Medical Disposables Market Top Leaders and Recent Innovation
- 3M
- Medline Industries
- Cardinal Health
- Becton, Dickinson & Company (BD)
- Baxter International
- B. Braun Melsungen
- Kimberly-Clark Health / Halyard Health
- Ansell
- Smiths Medical
- Terumo Corporation
- Mölnlycke Health Care
- ConvaTec
- Coloplast
- Fresenius Kabi
- Owens & Minor
- Henry Schein
- Nipro Medical
- Teleflex
- Cook Medical
- Top regional manufacturers & private-label converters
Market Growth
The global medical disposables market size is estimated at US$ 523.12 billion in 2024, is projected to grow to US$ 596.04 billion in 2025, and is expected to reach around US$ 1933.06 billion by 2034. The market is projected to expand at a CAGR of 13.94% between 2025 and 2034.
Medical Disposables Market Trends
Increasing applications of medical disposables are significant in making patient care better and lowering infection, which drives the growth of the market.
For instance,
- In January 2024, the Indian government started initiatives to boost India’s medical device sector. A large number of medical devices produced in India are disposables, such as catheters, perfusion sets, extension lines, cannulas, feeding tubes, needles, and syringes, as well as implants such as cardiac stents, drug-eluting stents, intraocular lenses, and orthopedic implants.
Increasing demand for medical disposables due to increasing healthcare demands, improving hygiene, lowering infection challenges, and enhancing efficiency drives the growth of the market.
For Instance,
- In June 2025, Coherent Corp., a global leader in photonics, announced the launch of its new line of disposable surgical fiber assemblies designed specifically for a wide range of precision medical applications. The new product line is suitable for both OEM integration and direct clinical use.
Medical Disposables Market – Value Chain Analysis
R&D
The R&D phase of medical disposables starts with an inspection of end-user requirements and technology potentials relevant to the medical device ideas. The early R&D phase lays the basic foundation for medical disposable product design efforts. By design, validation and verification testing confirm the medical device meets product needs and conditions.
Key Players: Medtronic, Abbott, Johnson & Johnson, Becton, Dickinson and Company (BD), Cardinal Health, Siemens Healthineers, 3M Company, and Stryker
Clinical Trials
Clinical trials of medical consumables include laboratory and animal research that appraise the medical device's safety and performance under controlled conditions. Phase I trials are important in the advancement of medical devices as they offer appreciated insights related to how the medical disposable interacts with the human body.
Key Players: IQVIA, Parexel, ICON, Syneos Health, and Charles River Laboratories
Patient Support and Services
The most significant role of medical consumables is to enhance patient safety and the quality of care they receive. This is achieved when physicians have more access to accurate devices at the right time, enabling them to accomplish the inspections, diagnostic testing, and therapies indicated to the maximum standard.
Key Players: 3M, Johnson & Johnson, Medline Industries, and Abbott
Latest Announcements by Industry Leaders
In May 2025, Darin Hammers, Chief Executive Officer at Minerva Surgical, stated, “The HERizon Hysto-Kit is a practical extension to our portfolio, designed to support the growing demand for in-office hysteroscopy. By bundling essential single-use supplies into one streamlined kit, we’re helping to simplify setup and support procedural consistency for clinicians and their teams.”
Recent Developments in the Medical Disposables Market
- In April 2025, KYRA Medical, Inc., has a proven track record of developing and manufacturing specialized medical devices for patient positioning in the operating room, servicing clinicians, global distribution partners, and industry-leading OEM partners. In this next exciting phase of global business expansion, it has made a strategic decision to open a new UK subsidiary to strengthen its presence in the UK and European markets, improve supply-chain efficiency, and better service our global network of customers.
- In November 2024, Henry Schein, Inc., the world’s largest provider of health care solutions to office-driven dental and medical practitioners, announced that it had signed an agreement to acquire Acentus, a national medical supplier specializing in the delivery of Continuous Glucose Monitors (CGMs).
- In May 2025, Minerva Surgical, a leader in minimally invasive gynecologic technologies, announced the launch of the HERizon Hysto-Kit, a single-use, pre-assembled kit designed to simplify office-based hysteroscopy procedures. The HERizon kit is designed to help Ob/Gyn physicians and their clinical staff save time, lower setup complexity, and maintain procedural consistency in the outpatient setting.
- In June 2025, Fresenius Medical Care (FME), the world’s leading provider of products and services for people with kidney disease, unveiled its new FME Reignite strategy at its Capital Markets Day in London.
Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com
